Domain Therapeutics
Domain Therapeutics is a series a startup based in France. 2 investors tracked.
About Domain Therapeutics
Based in France, Domain Therapeutics is a startup founded in 2017. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Domain Therapeutics is a biopharmaceutical company specializing in the discovery and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology. The company leverages its expertise in GPCR science to develop breakthrough therapies addressing unmet medical needs, particularly in cancer treatment by targeting GPCR-mediated immunosuppression.
Explore Domain Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.